Maspin protein in colorectal cancer
Part of Cancer, Digestive system clinical trials.
This study looks at a protein called maspin in colorectal cancer tissue to see if it can help predict how the disease might progress. It may help doctors better understand your cancer and guide treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with colorectal cancer at any stage.
- Your tumor tissue sample (paraffin block) is available for testing.
- Your clinical information is available for review.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is studying patients with colorectal cancer who are scheduled for surgery. Researchers want to learn more about the cancer to improve future treatments.
This study looks for biological markers (clues in your body) to predict where colorectal cancer might come back or spread. It aims to help doctors personalize follow-up care and treatment decisions for each patient.
This study looks at special tiny cell-signal particles (called exosomes) and related pathways to understand colorectal cancer. Your results from samples may help researchers learn how these signals relate to the disease after surgery.
This trial is testing if a protein called MMP-14 in small blood particles (exosomes) can help detect colorectal cancer. If you are having a colonoscopy because of a positive stool test, you may be able to join and help researchers learn more about this possible new marker.
This study looks at a protein called PD-L1 in tissue samples from people with colorectal cancer. It may help doctors understand the cancer better and guide future treatments.
This study looks at how certain blood markers (nucleosome and CTCF) clear from the body in people with colorectal cancer that has spread to the lining of the belly. It also includes people with other conditions to compare. The goal is to learn more about these markers to help guide treatment.
Hear when a new Maspin in Colorectal Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.